Medeva beefs up France and US with pounds 258m buy

Medeva, the pharmaceuticals group, yesterday announced a large expansion in the US and France with the $400m (pounds 258m) acquisition of rights to drugs and other assets from Rhone-Poulenc Rorer, the US-owned French drug company.

The US assets were acquired by RPR when it took over Fisons last year and include the group's former US headquarters at Rochester in New York State. They were spotted by Medeva as under-exploited during its abortive merger talks with Fisons.

The deal is being part-financed through a pounds 109m placing, with existing shareholders being offered the new shares on a one-for-six basis at 220p. The move was well received by analysts, who said it would be earnings- enhancing. Shares in Medeva jumped 30p to 261p.

Bill Bogie, chief executive, described the two acquisitions as "Medeva's most significant step forward in terms of both its operations and its potential to deliver earnings growth for shareholders". He said the deal took the group's strategy on several stages.

It gave them critical mass in France and the US. In the former, Dr Bogie said the acquisition of rights to respiratory, dermatological and non- prescription drugs would allow Medeva to cover the cost of the existing sales force, the marketing spend that goes with it and help to support new product launches.

The deals also give the group Fisons' pennkinetic slow release technology, which can be applied to products within Medeva's development pipeline, such as its Hepagene hepatitis vaccine and anaesthetics acquired last year. That would help turn the group into a fully-fledged pharmaceutical company into the next century, Dr Bogie said.

But he described the 10 products being acquired with the Rochester business as "a classic Medeva opportunity". In the six years of its life, the company had been good at generating and re-generating growth in the products its owns, he said, and the Rochester products had not had the support they required to generate growth.

The main drug being acquired is Tussionex, a treatment for heavy coughs, which generated $31.5m of the $99.7m sales produced in total by the US products last year. Delsym, a slow-release cough treatment for children, Pediapred, a steroid for treating a range of allergic to inflammatory conditions, Zaroxolyn, for heart and kidney failure, and Ionamin, an appetite suppressant, are also coming aboard in the deal.

Operating profits from the US drugs have grown from $36.3m to $54.4m in the last three years.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksA celebration of British elections
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: Trainee Recruitment Consultant - Swiss Banking and Finance

£20000 - £25000 per annum + Uncapped commission: SThree: Can you speak German,...

Ashdown Group: Marketing Executive - 6 month FTC - Central London

£25000 - £30000 per annum + benefits: Ashdown Group: An exciting opportunity f...

Ashdown Group: Junior Project Manager (website, web application) - Agile

£215 per day: Ashdown Group: Junior Project Manager (website, web application ...

Guru Careers: Software Engineer / Software Developer

£40-50K: Guru Careers: We are seeking an experienced Software Engineer / Softw...

Day In a Page

Fishing for votes with Nigel Farage: The Ukip leader shows how he can work an audience as he casts his line to the disaffected of Grimsby

Fishing is on Nigel Farage's mind

Ukip leader casts a line to the disaffected
Who is bombing whom in the Middle East? It's amazing they don't all hit each other

Who is bombing whom in the Middle East?

Robert Fisk untangles the countries and factions
China's influence on fashion: At the top of the game both creatively and commercially

China's influence on fashion

At the top of the game both creatively and commercially
Lord O’Donnell: Former cabinet secretary on the election and life away from the levers of power

The man known as GOD has a reputation for getting the job done

Lord O'Donnell's three principles of rule
Rainbow shades: It's all bright on the night

Rainbow shades

It's all bright on the night
'It was first time I had ever tasted chocolate. I kept a piece, and when Amsterdam was liberated, I gave it to the first Allied soldier I saw'

Bread from heaven

Dutch survivors thank RAF for World War II drop that saved millions
Britain will be 'run for the wealthy and powerful' if Tories retain power - Labour

How 'the Axe' helped Labour

UK will be 'run for the wealthy and powerful' if Tories retain power
Rare and exclusive video shows the horrific price paid by activists for challenging the rule of jihadist extremists in Syria

The price to be paid for challenging the rule of extremists

A revolution now 'consuming its own children'
Welcome to the world of Megagames

Welcome to the world of Megagames

300 players take part in Watch the Skies! board game in London
'Nymphomaniac' actress reveals what it was really like to star in one of the most explicit films ever

Charlotte Gainsbourg on 'Nymphomaniac'

Starring in one of the most explicit films ever
Robert Fisk in Abu Dhabi: The Emirates' out-of-sight migrant workers helping to build the dream projects of its rulers

Robert Fisk in Abu Dhabi

The Emirates' out-of-sight migrant workers helping to build the dream projects of its rulers
Vince Cable interview: Charging fees for employment tribunals was 'a very bad move'

Vince Cable exclusive interview

Charging fees for employment tribunals was 'a very bad move'
Iwan Rheon interview: Game of Thrones star returns to his Welsh roots to record debut album

Iwan Rheon is returning to his Welsh roots

Rheon is best known for his role as the Bastard of Bolton. It's gruelling playing a sadistic torturer, he tells Craig McLean, but it hasn't stopped him recording an album of Welsh psychedelia
Morne Hardenberg interview: Cameraman for BBC's upcoming show Shark on filming the ocean's most dangerous predator

It's time for my close-up

Meet the man who films great whites for a living
Increasing numbers of homeless people in America keep their mobile phones on the streets

Homeless people keep mobile phones

A homeless person with a smartphone is a common sight in the US. And that's creating a network where the 'hobo' community can share information - and fight stigma - like never before